Patrick Verheyen - 02 Jan 2024 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Patrick Verheyen by Colin Sandercock, attorney-in-fact
Issuer symbol
CUE
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 16:01:25 UTC
Previous filing
13 Apr 2023
Next filing
03 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Stock Option (right to buy) Award $0 +24,400 $0.000000 24,400 02 Jan 2024 Common Stock 24,400 $2.78 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
F2 This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date.